Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
Completed strategic pivot from R&D focus to commercial focus Rebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relations Advanced multiple recombinant protein programs toward …